1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Deals

Venture Life Snaps Up Netherlands’ Pharma Source

 
• By Tom Gallen

Consumer Health player Venture Life is expanding its reach in mainland Europe with the acquisition of Dutch medical devices specialist Pharma Source.

Businessman_Jigsaw
• Source: Shutterstock

UK-based consumer health player Venture Life Group has expanded its product portfolio and broadened its reach in Europe with the acquisition of Pharma Source BV for an initial €5.23m ($5.81m), plus a deferred contingent consideration of up to €1.27m.

Netherlands-based development and distribution firm Pharma Source markets a range of medical devices across many therapeutic areas including fungal nail...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

Navamedic To Market OTC Naloxone In Norway Following Switch

 
• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Reckitt Strikes Deal To Sell Essential Home Unit To Focus On CHC, Hygiene

 
• By Tom Gallen

Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

 
• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Haleon Takes Full Control Of China JV

 
• By Tom Gallen

Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."

More from Business

Euro Q2 Consumer Health Earnings Preview: Reckitt, Haleon, Bayer

 
• By Tom Gallen

Major Europe-based consumer health players Reckitt, Haleon and Bayer feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q2 2025 results over the coming weeks.

People On The Move: Appointments at BioGaia, Assosalute, Bayer

 
• By Tom Gallen

A round-up of the latest European people moves: BioGaia hires new subsidiary head from L'Oréal; Assosalute gets new director; Bayer renews contract of CEO.

Navamedic To Market OTC Naloxone In Norway Following Switch

 
• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.